The authors of "Targeted inactivation of β1 integrin induces β3 integrin switching, which drives breast cancer metastasis by TGF-β" (Mol. Biol. Cell \[2013\] 24, 3449--3459; originally published in *MBoC In Press* as 10.1091/mbc.E12-10-0776) wish to make a correction to the text of the article. In the original HTML and PDF versions, two numbers in column 1 of [Table 1](#T1){ref-type="table"} are incorrect. The numbers are listed as 324.45 (±70.8) and 110.4 (±15.8)\*, but should be 110.4 (±15.8)\* and 324.45 (±70.8)\*. The corrected Table appears below.

The HTML and PDF versions were corrected on January 20, 2014. These corrections may not appear on copies of the article that reside on other websites.

###### 

Functional disruption of β3 integrin inhibits primary tumor growth.

  Experimental condition      Final tumor volume (mm^3^)   Final tumor weight (mg)
  --------------------------- ---------------------------- -------------------------
  Experiment 1                                             
  Green fluorescent protein   110.4 (±15.8)\*              187.4 (±23.2)
  WT-β3 integrin              324.45 (±70.8)\*             426.7 (±39.6)\*
  D119A-β3 integrin           59.5 (±11.5)\*               148.5 (±29.1)
  Experiment 2                                             
  Scram                       1233.9 (±40.2)               132.2 (±8.3)
   Shβ3 integrin              694.6 (±47.3)\*\*            71.0 (±7.3)\*\*\*

Parental (GFP) or WT-β3 integrin-- or D119A-β3 integrin--expressing 4T1 cells (12,000 cells/mouse; experiment 1) and parental (Scram) or β3 integrin-deficient 4T1 cells (10,000 cells/mouse; experiment 2) were engrafted into the fat pads of syngeneic BALB/c mice. Tumor development was monitored over a span of 4 wk. Data are mean (±SE; *n* = 5) final tumor volumes and weights (\**p* \< 0.05; \*\**p* \< 0.0005; \*\*\**p* \< 0.000005).
